“…The drugs tested were 85 newly synthesized compounds and 12 commercial compounds belonging to the following chemical groups: (1) simple piperazines: PI-1, PI-2, PI-3, PI-4, PI-5, PI-6 (synthesized as per Raviña et al 1996), PI-8, PI-9 (Raviña et al 1995), PI-10 (Raviña et al 1999), PI-12 (Estévez et al 1998) and the commercial simple piperazines PCP (piperazine citrate pentahydrate, FLUKA), PDH-1 (piperazine dihydrochloride hydrate, FLUKA), PCA-1 (S-2 piperazine carboxylic acid dihydrochloride, FLUKA), PNP (1-phenylpiperazine, SIGMA), P2C (1-(2-chlorophenyl) piperazine monohydrochloride, SIGMA), P3C (1-(3-chlorophenyl) piperazine hydrochloride, SIGMA), P4C (1-(4-chlorophenyl) piperazine dihydrochloride, SIGMA), PBF (1-(α,α,α-trifluoro-m-tolyl) piperazine, SIGMA), PAC (4'-piperazinoacetophenone, SIGMA), CNP (trans-1-cinnamylpiperazine, SIGMA), norfloxacin (PN in Table 1) and lomefloxacin (PL in Table 1) (SIGMA, ALDRICH). (2) Naphthyridines 2b, 2d, 2e, 2f, 2g, 2i, 2j, 2k, 5o (synthesized as per Quintela et al 2003a).…”